IPO registrations (S-1, F-1) · Registrants
DELTAGEN INC
- SEC CIK
- 1034072 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2000-04-13, last 2000-08-02; 1 initial registration, 4 amendments
- Outcome
- Final prospectus filed 2000-08-03
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- 740 BAY ROAD, Redwood City, CA 94063-2469
- EIN
- 94-3260659
- EDGAR entity type
- operating
Offering terms
- Proposed price range
- $13.00–$15.00 per share (S-1/A filed 2000-08-02)
- Final price
- $15.00 per share, within the range (424B4 filed 2000-08-03, an initial public offering)
- Shares sold
- 7,000,000
- Gross proceeds
- $105,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol DGEN
- Lead underwriters
- Citigroup (2,772,000 shares); Robertson Stephens (2,268,000 shares); Piper Sandler (1,260,000 shares)
- Syndicate
- Hambrecht & Quist (85,000); CIBC World Markets (85,000); J.P. Morgan (85,000); Cowen (85,000); Legg Mason (60,000); Needham & Company (60,000); Pacific Growth Equities, Inc (60,000); Punk, Ziegel & Company, L.P (60,000); Truist Securities (60,000); Tucker Anthony Incorporated (60,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Federal award recipient: DELTAGEN, INC. Fuzzy (name and state)
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-04-13 | S-1 | S-1 (registration) | DELTAGEN INC | 0000912057-00-017738 ↗ |
| 2000-06-15 | S-1/A | S-1/A (amendment) | DELTAGEN INC | 0000912057-00-028798 ↗ |
| 2000-07-17 | S-1/A | S-1/A (amendment) | DELTAGEN INC | 0000912057-00-032107 ↗ |
| 2000-07-24 | S-1/A | S-1/A (amendment) | DELTAGEN INC | 0000912057-00-032952 ↗ |
| 2000-08-02 | S-1/A | S-1/A (amendment) | DELTAGEN INC | 0000912057-00-034179 ↗ |
| 2000-08-03 | 424B4 | 424B4 (final prospectus) | DELTAGEN INC | 0000912057-00-034473 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-08-02 | S-1/A | registration statement | $13.00–$15.00 | 7,000,000 | - | Nasdaq DGEN | 3 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 3 | document ↗ | |
| 2000-08-03 | 424B4 | final prospectus | $15.00 | 7,000,000 | $105,000,000 | Nasdaq DGEN | 13 | primary document; price sentence, shares headline, proceeds table, underwriting table 13, cover names 3 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Federal award recipient | DELTAGEN, INC. | CA | Federal spending (USAspending) | name and state |
| IPO registrant | FOXHOLLOW TECHNOLOGIES, INC. | CA | IPO registrations (S-1, F-1) | same street address and ZIP code, 740 BAY RD 94063 (FUZZY: a shared address, not proof of a shared organization) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, CA first:
- COMBICHEM INC CA
- AURORA BIOSCIENCES CORP CA
- SIGNAL PHARMACEUTICALS INC CA
- MAXYGEN INC CA
- KOSAN BIOSCIENCES INC CA
- CytoCore, Inc. CA
- diaDexus, Inc. (pre-merger) CA
- SENOMYX INC CA
- DNA SCIENCES INC CA
- KINEMED INC CA
In other datasets, the same topic (Medical research) in CA:
- Nonprofit: 23ANDME RESEARCH INSTITUTE (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research